Skip to main content

Juan Garrido Oliver

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Juan Garrido Oliver

Institutions of which they are part

Predoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Mapeo del crecimiento aórtico y refinamiento del genotipo para avanzar en la medicina de precisión en los síndromes de Marfan y Loeys-Dietz (AGM4Gen)

IP: Gisela Teixido i Tura
Collaborators: Juan Garrido Oliver, Ruperto Olivero Soldevila, Alicia Fresno González, Alberto Roque Pérez, Javier Limeres Freire
Funding agency: Ministerio Ciencia, Innovación y Universidades
Funding: 112500
Reference: PID2024-159353OB-I00
Duration: 01/09/2025 - 31/08/2028

Ministerio de Ciencia

Artificial intelligence for the quantitative assessment of aortic valve calcification on echocardiography images

IP: Andrea Guala
Collaborators: Ignacio Ferreira González, Pere López Gutierrez, Jose Fernando Rodríguez Palomares, Gisela Teixido i Tura, Juan Garrido Oliver, Lydia Dux-Santoy Hurtado, Laura Galián Gay
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/GUALA/2024
Duration: 01/10/2024 - 31/12/2028

DVPS: Diversis Viis, Plurima Solvens

IP: Andrea Guala
Collaborators: Ignacio Ferreira González, Pere López Gutierrez, Pere López Gutierrez, Jose Fernando Rodríguez Palomares, Eduardo Ródenas Alesina, Juan Garrido Oliver, Alicia Fresno González, Toni Soriano Colomé, Lydia Dux-Santoy Hurtado, Juan Pablo Betancur Rengifo
Funding agency: EUROPEAN COMMISSION
Funding: 462500
Reference: DVPS
Duration: 01/07/2025 - 30/06/2029

Role of amino acid metabolism reprogramming and calpain deregulation in fibroblasts activation and diffuse myocardial fibrosis in heart failure

IP: Javier Inserte Igual
Collaborators: José Antonio Barrabés Riu, David Aluja Gonzalez, Juan Garrido Oliver, Elisabet Miro Casas, Sara Delgado Tomás
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/00068
Duration: 01/01/2024 - 31/12/2027

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Eva Maria Fernández Mondragón

Eva Maria Fernández Mondragón

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Miriam Tudela Trancoso

Miriam Tudela Trancoso

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Vanesa Asenjo Gómez

Vanesa Asenjo Gómez

Research technician
Donation and transplantation of organs, tissues and cells
Read more
Mónica Diez Poch

Mónica Diez Poch

Predoctoral researcher
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.